2011 Q2/Global Life Sciences


Summary

Full results


Changes in rank are compared to 2011 Q1/Global Life Sciences. Since then, 3 sites entered the survey and 10 sites could not be included in the rankings (2 fewer since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
+ 25 Siegfried AG 8.36
- 1 Cilag AG 8.31
same Lumavita AG 8.12
+ 2 Nycomed Pharma AG 8.08
- 1 Newron 8.03
+ 1 Axentis Pharma AG 7.98
- 5 Actelion Ltd. 7.82
- 3 Medinova AG 7.75
+ 9 4-Antibody AG 7.57
+ 55 Nycomed International Management GmbH 7.48
- 3 Neurimmune Therapeutics AG 7.20
+ 26 Vifor (International) Ltd. 7.00
+ 26 Helvepharm AG 7.00
- 5 Antares Pharma AG 6.93
+ 15 Kuros Biosurgery AG 6.91
+ 57 F. Hoffmann-La Roche AG (Worldwide) 6.90
- 5 Pharmakon Ltd. 6.79
- 4 Med Discovery S.A. 6.75
+ 59 MEDA Pharma GmbH 6.69
- 4 Pentapharm (DSM Nutritional Products AG) 6.68
- 4 BioPartners GmbH 6.68
- 11 Takeda Pharma AG 6.65
+ 53 Tillotts Pharma AG 6.56
- 14 ArisGen SA 6.49
- 10 Neurotune 6.33
- 2 Tricom GmbH, Pharma Division 6.32
- 2 GlaxoSmithKline AG 6.31
- 7 AmVac AG 6.25
- 2 Auris Medical AG 6.23
- 10 OMIDA AG 6.22
+ 3 GKL Biotec AG 6.20
- 3 Molecular Partners 6.15
- 14 Dr. Wild & Co. AG 6.12
- 3 Virbac Schweiz AG 6.06
- 3 Cytos Biotechnology AG 5.95
- 1 Octapharma AG 5.91
- 1 Lipideon Biotechnology AG 5.88
- 10 Max Zeller Söhne AG 5.86
- 2 Biogen Idec International GmbH 5.76
- 17 Johnson & Johnson Pharmaceutical Research & Development 5.70
+ 6 Anavex Life Sciences Corp. 5.64
+ 14 Acino Holding AG 5.60
+ 1 A. Menarini AG 5.59
+ 1 Sanofi-Aventis 5.57
+ 4 Bristol-Myers Squibb SA 5.47
+ 4 BioVersys GmbH 5.45
+ 12 Debiopharm S.A. 5.38
- 8 Novartis International AG 5.36
- 16 Teva Pharma AG 5.33
+ 5 Novelty Pharma Galenical Development and Documentation 5.31
+ 16 Mundipharma Medical Company 5.30
+ 5 F. Hoffmann-La Roche AG (CH) 5.27
+ 8 Abbott Laboratories 5.20
- 41 Arpida AG 5.17
- 33 Evolva SA 5.17
- 2 AstraZeneca 5.07
- 6 Addex Pharmaceuticals 5.05
- 16 Permamed AG 4.94
+ 9 Covagen AG 4.89
+ 3 Lunamed AG 4.83
- 20 Galenica Ltd. 4.81
+ 2 Aurora Pharma GmbH 4.71
+ 18 NovImmune 4.70
- 2 Solvay Pharma AG 4.68
- 5 Basilea Pharmaceutica Ltd. 4.63
same Ergonex Pharma GmbH 4.58
+ 16 Mepha Pharma AG 4.49
- 22 Merz Pharma (Schweiz) AG 4.48
+ 3 Boehringer Ingelheim Schweiz GmbH 4.45
- 17 Novo Nordisk Pharma AG 4.40
- 13 Spirig Pharma AG 4.40
- 20 Ferring International Center SA 4.32
- 30 AstraZeneca AG 4.26
+ 1 LEO Pharmaceutical Products Sarath Ltd. 4.23
+ 2 3-V Biosciences GmbH 4.21
+ 3 GlycoVaxyn AG 4.12
- 7 Kenta Biotech AG 4.12
+ 2 Streuli Pharma AG 4.12
- 10 AC Immune SA 4.02
+ 4 Nitec Pharma AG 4.01
+ 1 mondoBIOTECH AG 3.95
- 11 CSL Behring AG 3.94
+ 3 Multipharma 3.88
+ 4 Merck Serono International SA 3.83
- 11 Medipol SA 3.79
+ 3 Medena 3.61
+ 3 Gruenenthal Pharma AG 3.60
+ 5 OM PHARMA 3.54
- 4 Novartis Pharma Schweiz AG 3.40
+ 1 Crucell | Berna Biotech Ltd 3.32
+ 4 Galderma Pharma SA 3.30
+ 4 Pfizer 3.20
+ 4 Redbiotec AG 3.17
- 2 Johnson & Johnson 3.16
- 1 Lundbeck (Schweiz) AG 3.13
+ 4 ESBATECH AG 3.04
new Allergan AG 3.04
+ 5 PharmaSwiss SA - HQ 2.97
+ 3 GeNeuro SA 2.96
- 2 PFC Pharma Focus Switzerland 2.80
- 14 Eli Lilly 2.69
+ 3 GenKyoTex SA 2.61
+ 1 GlaxoSmithKline 2.60
- 5 Cryo-Save AG 2.58
+ 1 Schwabe Pharma AG 2.53
+ 3 Bristol-Myers Squibb 2.24
same Merck Sharp & Dohme-Chibret AG 2.21
+ 2 Geistlich Pharma AG 2.16
+ 2 APR Applied Pharma Research s.a. 2.15
+ 5 Neurim Pharmaceuticals S.A. 2.11
- 10 Bayer Schweiz AG 2.07
same Genzyme GmbH 1.91
+ 1 Helsinn Healthcare S.A. 1.83
- 1 Merck 1.62
new Wyeth Pharmaceuticals AG 1.45
new Pfizer (Switzerland) 1.45
- 9 Baxter Switzerland 1.06